Hilltop Holdings’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-121,755
Closed -$1.7M 683
2026
Q1
$1.7M Sell
121,755
-161,161
-57% -$2.26M 0.15% 152
2025
Q4
$4.07M Buy
+282,916
New +$4.25M 0.24% 97
2024
Q4
Sell
-45,681
Closed -$895K 845
2024
Q3
$895K Buy
+45,681
New +$909K 0.06% 340

Other funds holding BTAL

Hilltop Holdings's BTAL Position: Q2 2026 in Review

Hilltop Holdings sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 121,755 shares — an estimated $1.7M sold.

Hilltop Holdings first reported a position in BTAL in Q3 2024 and held it in 3 quarters. The position peaked at $4.07M in Q4 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Hilltop Holdings reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • Hilltop Holdings sold 121,755 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $1.7M.
  • Hilltop Holdings first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2024 and held it in 3 quarters.
  • Hilltop Holdings's AGF US Market Neutral Anti-Beta Fund position peaked at $4.07M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.